Literature DB >> 2936802

Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes.

J Suttles, G A Schwarting, R D Stout.   

Abstract

Previous studies have demonstrated that natural killer (NK) cells express the glycolipid asialo GM1, as evidenced by the sensitivity of NK cells to treatment with anti-asialo GM1 serum and complement. Because alloimmune cytotoxic T lymphocytes (CTL) were found to be insensitive to treatment with anti-asialo GM1 serum and complement, it was concluded that asialo GM1 is expressed by NK but not by CTL. However, fluorescence studies indicated that a significant proportion of peripheral T cells did express asialo GM1. Flow cytometric studies were undertaken to determine the extent to which alloimmune CTL express asialo GM1. Affinity-purified, monospecific IgG anti-asialo GM1 antibodies were used to label cells from mixed lymphocyte cultures. Separation of asialo GM1-positive and -negative fractions by cell sorting revealed that the majority of CTL activity resides in the asialo GM1-positive population. When these studies are compared with similar studies of splenic NK activity, it is apparent that, despite the relative insensitivity of CTL to treatment with anti-asialo GM1 and complement, both CTL and NK activity are enriched in the asialo GM1-positive cell population obtained by cell sorting.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936802

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Simultaneous development of cells with large granular lymphocyte (LGL) morphology and natural killer (NK) cell lytic activity after bone marrow (BM) transplantation in mice.

Authors:  O Silvennoinen; M Hurme
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

2.  Expression of T-cell associated antigens by porcine natural killer cells.

Authors:  M D Pescovitz; M A Lowman; D H Sachs
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

3.  Curative effects of combination therapy with lentinan and interleukin-2 against established murine tumors, and the role of CD8-positive T cells.

Authors:  M Suzuki; T Kikuchi; F Takatsuki; J Hamuro
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

4.  Natural killer cells mediate protection induced by a Salmonella aroA mutant.

Authors:  R Schafer; T K Eisenstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

5.  Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.

Authors:  T M Scharton; P Scott
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

6.  Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.

Authors:  N Fujioka; R Akazawa; K Ohashi; M Fujii; M Ikeda; M Kurimoto
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Experimental studies of immunologically mediated enteropathy. II. Role of natural killer cells in the intestinal phase of murine graft-versus-host reaction.

Authors:  A M Mowat; M V Felstein
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

8.  Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity.

Authors:  Hasan Zeytin; Eva Reali; David A Zaharoff; Connie J Rogers; Jeffrey Schlom; John W Greiner
Journal:  J Interferon Cytokine Res       Date:  2008-02       Impact factor: 2.607

9.  Enhanced therapeutic effects of anti-tumour agents against growth and metastasis of colon carcinoma 26 when given in combination with interferon and interleukin-2.

Authors:  M Iigo; H Tsuda; M Moriyama
Journal:  Clin Exp Metastasis       Date:  1994-11       Impact factor: 5.150

10.  In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice.

Authors:  K V Harshan; P R Gangadharam
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.